International Journal of Inflammation Research
Publishing groundbreaking research in inflammation mechanisms, immune regulation, cytokine signaling, chronic inflammatory diseases, therapeutic interventions, and biomarker discovery advancing our understanding of inflammatory pathophysiology and improving patient outcomes through evidence-based anti-inflammatory treatments worldwide. Join a dynamic international community of immunologists, rheumatologists, molecular biologists, clinical researchers, and pharmaceutical scientists pioneering next-generation anti-inflammatory therapeutics and precision medicine approaches.
Bridging Discovery and Clinical Application
The International Journal of Inflammation Research serves as the premier platform for disseminating cutting-edge research advancing our understanding of inflammatory mechanisms from molecular pathways to clinical therapeutics. Our rigorous peer review by inflammation biology experts ensures the highest scientific standards while accelerating knowledge translation improving anti-inflammatory treatment efficacy and patient outcomes globally through evidence-based interventions targeting inflammatory pathophysiology across diverse disease states. Since its establishment, IJIR has published landmark studies elucidating novel inflammasome activation pathways, identifying therapeutic targets in chronic inflammatory conditions, and advancing biomarker discovery for predicting treatment response in autoimmune disorders.
We publish comprehensive investigations spanning acute inflammation resolution pathways, chronic inflammation perpetuation mechanisms including persistent immune activation and tissue remodeling, inflammatory cytokine networks involving TNF-alpha IL-1 IL-6 and IL-17 signaling cascades, inflammasome activation through NLRP3 and AIM2 pathways driving IL-1beta and IL-18 secretion, resolution mediators including lipoxins resolvins protectins and maresins promoting inflammation resolution, anti-inflammatory therapeutic strategies targeting cytokines kinases and transcription factors, and biomarker development predicting disease activity therapy response and clinical outcomes advancing personalized anti-inflammatory medicine benefiting patients with rheumatoid arthritis inflammatory bowel disease psoriasis atherosclerosis and other inflammatory conditions worldwide.
IJIR membership provides researchers with privileged access to an accelerated editorial workflow, reduced publication costs, and direct engagement with a global network of inflammation scientists. Our editorial board comprises internationally recognized experts spanning innate immunity, adaptive immune regulation, mucosal immunology, neuroimmunology, and clinical rheumatology ensuring comprehensive domain coverage and authoritative scientific evaluation. Members benefit from dedicated manuscript handling coordinators who guide submissions through every stage of the peer review and production process, minimizing administrative burden and maximizing research dissemination efficiency.
Research Focus Areas
Comprehensive coverage across inflammation biology domains advancing mechanistic understanding and therapeutic development
Innate Immunity
Pattern recognition receptor signaling through TLRs and NLRs detecting PAMPs and DAMPs triggering inflammatory cascades defending against pathogens while causing tissue damage. Research encompasses neutrophil extracellular trap formation, macrophage polarization dynamics, complement system activation, and trained immunity mechanisms reshaping innate immune memory responses
Cytokine Networks
Pro-inflammatory cytokine production regulation secretion and signaling mechanisms coordinating immune cell recruitment activation and inflammatory mediator amplification. Studies include TNF-alpha superfamily interactions, interleukin signaling cascades involving IL-1beta IL-6 IL-12 IL-17 and IL-23 axes, chemokine gradient formation, and cytokine storm pathophysiology in severe inflammatory conditions
Resolution Mechanisms
Active inflammation resolution through specialized pro-resolving mediators efferocytosis of apoptotic cells and M2 macrophage polarization restoring tissue homeostasis. Investigations cover lipoxin biosynthesis, resolvin and protectin signaling pathways, maresin-mediated tissue regeneration, and therapeutic strategies promoting active resolution in chronic inflammatory diseases
Chronic Inflammation
Failed resolution pathways persistent immune activation tissue fibrosis and remodeling underlying rheumatoid arthritis inflammatory bowel disease atherosclerosis and cancer. Research addresses the transition from acute to chronic inflammation, epigenetic reprogramming of immune cells, metabolic rewiring in inflammatory microenvironments, and organ-specific fibrotic mechanisms driving progressive tissue damage
Targeted Therapies
Biologic agents blocking TNF IL-6 IL-17 JAK inhibitors small molecule kinase inhibitors and novel anti-inflammatory strategies improving clinical outcomes. Coverage includes biosimilar development and clinical equivalence studies, combination therapy optimization, nanoparticle-based drug delivery systems for targeted anti-inflammatory treatment, and emerging cell-based therapies including regulatory T-cell and mesenchymal stem cell approaches
Membership Advantages
Experience premium benefits designed to accelerate your inflammation research impact and professional development
Expert Peer Review
Manuscripts receive evaluation by internationally recognized inflammation biology and immunology specialists with deep domain expertise matching your research focus ensuring rigorous scientific assessment and constructive feedback improving manuscript quality before publication.
Accelerated Publication
Members receive expedited manuscript handling with priority editorial screening within seventy-two hours, accelerated peer review averaging four weeks for initial decisions, and fast-track publication within three weeks following acceptance for practice-changing research requiring immediate dissemination to the inflammation research community.
Global Research Impact
Open access publication ensures your inflammation research immediately reaches immunologists developing novel therapeutics, clinicians treating inflammatory diseases, pharmaceutical companies advancing drug development programs, and regulatory agencies developing evidence-based treatment guidelines worldwide.
Cost Savings
Membership provides thirty to fifty percent reductions on article processing charges enabling dissemination of more inflammation research while managing constrained grant budgets efficiently supporting academic institutions, hospital research departments, and pharmaceutical R&D laboratories.
Research Network
Connect with leading immunology research institutions, university rheumatology departments, national health institutes, pharmaceutical companies developing anti-inflammatory therapeutics, and clinical trial organizations advancing evidence-based inflammatory disease management worldwide.
The IJIR research community encompasses leading immunology departments training next-generation inflammation scientists, university hospitals conducting translational inflammatory disease research, pharmaceutical companies investing in novel anti-inflammatory drug discovery, biotechnology firms developing targeted biologic therapies, clinical research organizations managing multi-center anti-inflammatory treatment trials, and government health agencies funding inflammation research programs enabling continued advancement in understanding inflammatory pathophysiology and developing more effective treatments benefiting patients with autoimmune diseases chronic inflammatory conditions and acute inflammatory emergencies worldwide.
Membership Investment
Select the membership tier that best supports your inflammation research dissemination goals and professional development needs. Each tier includes full open access publication with immediate worldwide visibility, expert peer review by inflammation biology specialists, and dedicated editorial support throughout the manuscript preparation and review process
Membership Questions?
Contact our editorial team for assistance with membership and publication inquiries.
[email protected]Publish Your Inflammation Research
Submit your inflammation biology and immunology research for expert peer review and immediate global open access distribution advancing inflammatory disease understanding worldwide. Whether your research explores novel inflammatory signaling pathways, develops targeted anti-inflammatory therapeutics, identifies diagnostic biomarkers, or advances clinical treatment protocols, IJIR provides a rigorous and responsive publication platform connecting your discoveries with the global inflammation research community.